{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:30:13Z","timestamp":1777962613844,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","award":["3150120001"],"award-info":[{"award-number":["3150120001"]}],"id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clbc.2022.04.001","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:11:37Z","timestamp":1649124697000},"page":"521-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma"],"prefix":"10.1016","volume":"22","author":[{"given":"Md. Nazim","family":"Uddin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2022.04.001_bib0001","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41571-018-0007-1","article-title":"Targeting the tumour stroma to improve cancer therapy","volume":"15","author":"Valkenburg","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clbc.2022.04.001_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13577-020-00427-6","article-title":"Diversity in cancer invasion phenotypes indicates specific stroma regulated programs","volume":"34","author":"Novin","year":"2021","journal-title":"Human Cell"},{"key":"10.1016\/j.clbc.2022.04.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118725","article-title":"The landscape of long non-coding RNAs in tumor stroma","volume":"264","author":"Uddin","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.clbc.2022.04.001_bib0004","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10555-013-9438-4","article-title":"Role of the host stroma in cancer and its therapeutic significance","volume":"32","author":"Tarin","year":"2013","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.clbc.2022.04.001_bib0005","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1878-0261.12107","article-title":"Prognostic and functional role of subtype-specific tumor\u2013stroma interaction in breast cancer","volume":"11","author":"Merlino","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.clbc.2022.04.001_bib0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4161\/cam.20567","article-title":"Why the stroma matters in breast cancer","volume":"6","author":"Conklin","year":"2012","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.clbc.2022.04.001_bib0007","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1007\/s11033-020-05853-1","article-title":"Chemotherapy resistance and stromal targets in breast cancer treatment: a review","volume":"47","author":"van der Spek","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.clbc.2022.04.001_bib0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12943-019-0960-z","article-title":"Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer","volume":"18","author":"Plava","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clbc.2022.04.001_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00262-007-0365-5","article-title":"Anti-cancer therapies targeting the tumor stroma","volume":"57","author":"Hofmeister","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clbc.2022.04.001_bib0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-005-0070-1","article-title":"Tumor stroma-associated antigens for anti-cancer immunotherapy","volume":"55","author":"Hofmeister","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.clbc.2022.04.001_bib0011","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.clbc.2022.04.001_bib0012","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12935-020-01173-3","article-title":"Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1\/PD-L1 immunotherapy and outcomes in patients with gastric cancer","volume":"20","author":"Ren","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.clbc.2022.04.001_bib0013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/2326-6066.CIR-16-0011","article-title":"Can targeting stroma pave the way to enhanced antitumor immunity and immunotherapy of solid tumors?","volume":"4","author":"Pur\u00e9","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13058-015-0579-y","volume":"17","author":"Yuan","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0015","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/cancers7040902","article-title":"Cancer-associated fibroblasts: their characteristics and their roles in tumor growth","volume":"7","author":"Shiga","year":"2015","journal-title":"Cancers"},{"key":"10.1016\/j.clbc.2022.04.001_bib0016","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/onc.2014.224","article-title":"IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer","volume":"33","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.clbc.2022.04.001_bib0017","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2022.04.001_bib0018","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10549-019-05142-x","article-title":"Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up","volume":"175","author":"Yang","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.04.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1061176","article-title":"Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis","volume":"5","author":"Bonsang-Kitzis","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clbc.2022.04.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167397","article-title":"A stromal immune module correlated with the response to neoadjuvant chemotherapy, prognosis and lymphocyte infiltration in her2-positive breast carcinoma is inversely correlated with hormonal pathways","volume":"11","author":"Hamy","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2022.04.001_bib0021","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm1764","article-title":"Stromal gene expression predicts clinical outcome in breast cancer","volume":"14","author":"Finak","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.clbc.2022.04.001_bib0022","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0530-2","article-title":"Prognostic stromal gene signatures in breast cancer","volume":"17","author":"Winslow","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0023","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ncponc0908","article-title":"Origins of breast cancer subtypes and therapeutic implications","volume":"4","author":"Sims","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.clbc.2022.04.001_bib0024","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.devcel.2017.04.024","article-title":"Discovery of stromal regulatory networks that suppress ras-sensitized epithelial cell proliferation","volume":"41","author":"Liu","year":"2017","journal-title":"Dev Cell"},{"key":"10.1016\/j.clbc.2022.04.001_bib0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12672-013-0136-z","article-title":"Genomic signatures of pregnancy-associated breast cancer epithelia and stroma and their regulation by estrogens and progesterone","volume":"4","author":"Harvell","year":"2013","journal-title":"Horm Cancer"},{"key":"10.1016\/j.clbc.2022.04.001_bib0026","doi-asserted-by":"crossref","first-page":"e18640","DOI":"10.1371\/journal.pone.0018640","article-title":"Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer","volume":"6","author":"Planche","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2022.04.001_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10549-008-9982-8","article-title":"Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer","volume":"114","author":"Casey","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.04.001_bib0028","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2022.04.001_bib0029","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10549-011-1894-3","article-title":"Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia","volume":"133","author":"Knudsen","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2022.04.001_bib0030","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/bcr2222","article-title":"Gene expression profiling of the tumor microenvironment during breast cancer progression","volume":"11","author":"Ma","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"6","key":"10.1016\/j.clbc.2022.04.001_bib0031","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nprot.2015.052","article-title":"NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data","volume":"10","author":"Xia","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.clbc.2022.04.001_bib0032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.clbc.2022.04.001_bib0033","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2022.04.001_bib0034","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1471-2164-9-239","article-title":"Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen","volume":"9","author":"Loi","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.clbc.2022.04.001_bib0035","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.0907011107","article-title":"PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer","volume":"107","author":"Loi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2022.04.001_bib0036","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2022.04.001_bib0037","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"10.1016\/j.clbc.2022.04.001_bib0038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.clbc.2022.04.001_bib0039","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2022.04.001_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.clbc.2022.04.001_bib0041","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"D1","key":"10.1016\/j.clbc.2022.04.001_bib0042","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-018-1002-1","article-title":"Classification of triple-negative breast cancers based on Immunogenomic profiling","volume":"37","author":"He","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0044","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1073\/pnas.1818210116","article-title":"Cancer stemness, intratumoral heterogeneity, and immune response across cancers","volume":"116","author":"Miranda","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2022.04.001_bib0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.clbc.2022.04.001_bib0046","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"10.1016\/j.clbc.2022.04.001_bib0047","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.clbc.2022.04.001_bib0048","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0049","unstructured":"Therneau T. A package for survival analysis in R. :95."},{"key":"10.1016\/j.clbc.2022.04.001_bib0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1755-8794-2-18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.clbc.2022.04.001_bib0051","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0052","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.clbc.2022.04.001_bib0053","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1158\/1078-0432.CCR-16-1761","article-title":"PD-L2 expression in human tumors: relevance to anti-PD-1 therapy in cancer","volume":"23","author":"Yearley","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0054","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clbc.2022.04.001_bib0055","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/bcr3472","article-title":"Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype","volume":"15","author":"Choi","year":"2013","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050642","article-title":"Consequences of EMT-driven changes in the immune microenvironment of breast cancer and therapeutic response of cancer cells","volume":"8","author":"Singh","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.clbc.2022.04.001_bib0057","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-735","article-title":"Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling","volume":"14","author":"Pinto","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.04.001_bib0058","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12885-018-4178-z","article-title":"Diagnostic and prognostic implications of ribosomal protein transcript expression patterns in human cancers","volume":"18","author":"Dolezal","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.04.001_bib0059","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.yexcr.2008.01.002","article-title":"Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene","volume":"314","author":"Yoshida","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.clbc.2022.04.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04864-8","article-title":"Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program","volume":"9","author":"Hirukawa","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2022.04.001_bib0061","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clbc.2022.04.001_bib0062","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.04.001_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.781848","article-title":"Identification of breast cancer immune subtypes by analyzing bulk tumor and single cell transcriptomes","volume":"9","author":"Yao","year":"2022","journal-title":"Front Cell Dev Biol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:43Z","timestamp":1761513823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820922000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1526820922000702"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2022.04.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Breast Cancer Subtypes Based on Gene Expression Profiles in Breast Cancer Stroma","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2022.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}